Discover 1,407 paid clinical trials in Cleveland, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,407
Active & Responsive
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Cleveland OH, Canton OH, Pittsburgh PA, Ann Arbor MI,
Sponsor: Bicara Therapeutics
Sex: All
Age: 18+
Code: NCT06788990
Phase 2, Phase 3, Recruiting
Active & Responsive
Changes in Microbial Status From Dentate, Edentulous and After Dental Implant Placement
Get alerts for new trials in your area by subscribing now
Active & Responsive
Multi-Site Detection of Barrett's Esophagus in Patients Without Chronic GERD Symptoms
for
Barrett Esophagus, Gastroesophageal Reflux,
Location: Cleveland OH, Baltimore MD, Chapel Hill NC, Aurora CO
Sponsor: Case Comprehensive Cancer Center
Sex: All
Age: 50+
Code: NCT06687603
Recruiting
Active & Responsive
Safety and Preliminary Efficacy of SA53-OS in Patients With Locally Advanced or Metastatic Solid Tumors
for
Solid Tumor
Location: Cleveland OH, Canton OH
Sponsor: Lamassu Bio Inc
Sex: All
Age: 18+
Code: NCT06578624
Phase 1, Phase 2, Recruiting
Active & Responsive
Is Intraperitoneal Drainage Necessary Following Distal Pancreatectomy?
for
Cyst of Pancreas, Pancreatectomy, Pancreas Neoplasm
Location: Cleveland OH
Sponsor: Case Comprehensive Cancer Center
Sex: All
Age: 18+
Code: NCT05720338
Phase 3, Recruiting
Active & Responsive
KEYMAKER-U04 Substudy 04D: A Clinical Study of New Treatments Given With Enfortumab Vedotin and Pembrolizumab in People With Urothelial Cancer (MK-3475-04D/KEYMAKER-U04)
for
Bladder Cancer
Location: Cleveland OH, Chicago IL, New York NY,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07232602
Phase 1, Phase 2, Recruiting
Active & Responsive
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
Location: Cleveland OH, Detroit MI, Pittsburgh PA, Ann Arbor MI,
Sponsor: Black Diamond Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT07326566
Phase 2, Recruiting
Active & Responsive
A Clinical Trial to Test if an Investigational Combination Therapy With BNT326 and BNT327 is Safe and Potentially Beneficial for People With Advanced Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Cleveland OH, Detroit MI, Fairfax VA,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT07111520
Phase 1, Phase 2, Recruiting
Active & Responsive
Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer